Provided by Tiger Fintech (Singapore) Pte. Ltd.

CRISPR Therapeutics AG

41.86
+3.298.53%
Post-market: 41.900.0684+0.16%19:59 EDT
Volume:4.73M
Turnover:195.75M
Market Cap:3.62B
PE:-9.27
High:42.36
Open:39.59
Low:39.59
Close:38.57
Loading ...
Mar 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 21, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 21, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 13, 2024

Major Issues Report

Form 8-K - Current report
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 05, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 30, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 16, 2024

Major Issues Report

Form 8-K - Current report
Jan 11, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 19, 2023

Major Issues Report

Form 8-K - Current report
Dec 15, 2023

Major Issues Report

Form 8-K - Current report
Dec 13, 2023

Major Issues Report

Form 8-K - Current report
Dec 08, 2023

Major Issues Report

Form 8-K - Current report
Dec 04, 2023

Major Issues Report

Form 8-K - Current report